Liprovia

About Ablatotech

Ablatotech is a visionary biotech firm founded by Dr. George Ekema, focused on disrupting traditional medicine by developing the DAPYTAP platform. This technology is positioned as a superior alternative to both vaccines and monoclonal antibody therapies, with the goal of making cutting-edge treatments globally accessible. The company has initiated clinical trials for its first candidates and is actively enrolling patients, signaling its transition from platform development to clinical validation.

Therapeutic Areas